Connecticut 2023 2023 Regular Session

Connecticut Senate Bill SB01059 Comm Sub / Analysis

Filed 06/01/2023

                     
Researcher: JSB 	Page 1 	6/1/23 
 
 
 
 
OLR Bill Analysis 
sSB 1059 (File 116, as amended by Senate "A")*  
 
AN ACT ESTABLISHING A TASK FORCE TO STUDY THE 
OPERATIONS OF THE DEPARTMENT OF CONSUMER 
PROTECTION.  
 
SUMMARY 
This bill makes pharmacists and pharmacy interns (hereinafter, 
“pharmacists and interns”) eligible for the professional assistance 
program for health professionals (currently, the Health Assistance 
InterVention Education Network (HAVEN); see BACKGROUND). By 
law, the program is an alternative, voluntary, and confidential 
rehabilitation program that provides various services to health 
professionals with a chemical dependency, emotional or behavioral 
disorder, or physical or mental illness. 
In doing so, the bill makes a number of minor and conforming 
changes to reflect the fact that the Department of Consumer Protection 
(DCP) regulates pharmacists and interns; currently, the professionals 
eligible for the program are regulated by the Department of Public 
Health (DPH). These corresponding changes include establishing 
separate but substantially similar provisions specifically for pharmacists 
and interns and giving DCP oversight of these professionals’ 
participation in the program (see below). But under the bill, DPH 
remains the lead agency responsible for the program (e.g., overseeing 
the program’s annual audit and oversight committee). 
The bill also correspondingly requires the assistance program to 
submit certain information on participating pharmacists and interns to 
the General Law Committee, like it currently submits to the Public 
Health Committee for other health professionals.   
The bill also raises the renewal credentialing fees for pharmacist and 
intern licensees by $5, to $105 and $65, respectively. It requires the DCP  2023SB-01059-R01-BA.DOCX 
 
Researcher: JSB 	Page 2 	6/1/23 
 
commissioner to transfer $5 from each renewal fee to the pharmacy 
professional assistance program account, which the bill creates as a 
separate, nonlapsing account. He must do so by the last day of January, 
April, July, and October, each year. The funds must be used by DCP for 
the assistance program (§§ 4 & 8-10).    
*Senate Amendment “A” replaces the underlying bill, which would 
have created a task force to study DCP’s operations.   
EFFECTIVE DATE: October 1, 2023, except the provisions on renewal 
fees are effective July 1, 2025.   
PARTICIPATION BY PHARMACISTS AND INT ERNS  
As is the case for the health professionals already eligible to 
participate in the assistance program, among other things, the bill: 
1. requires the assistance program to include a medical review 
committee that meets the bill’s requirements, which are 
substantially similar to existing law’s requirements for medical 
review committees (e.g., the committee must determine whether 
the professional is an appropriate candidate, set the terms for his 
or her participation, and refer specified individuals to DCP); 
2. makes professionals who have engaged in certain conduct 
ineligible to participate (e.g., conduct that has been subject to 
disciplinary action, actions that constitute a felony, or alleged to 
have harmed a patient);   
3. generally requires the program to keep information related to an 
intervention, rehabilitation, referral, or support services 
confidential; and 
4. specifies that if pharmacists or interns fail to comply with the 
program, it must notify DCP and transfer related records to the 
department.  
DCP’s Authority and Oversight  
To reflect DCP’s credentialing role for pharmacists and interns, the  2023SB-01059-R01-BA.DOCX 
 
Researcher: JSB 	Page 3 	6/1/23 
 
bill, among other things: 
1. gives DCP oversight of pharmacists’ and interns’ participation in 
the assistance program, including making DCP the agency that 
hospitals, health care practitioners, and the public notify if they 
believe a pharmacist or intern is unable to practice with 
reasonable skill or safety; 
2. requires the program to notify DCP if it determines a pharmacist 
or intern has engaged in conduct that makes him or her ineligible 
to participate or is engaging in conduct that violates the terms of 
his or her participation or endangers others; 
3. requires the program to annually report to DCP, if there is no 
other credentialing board or commission, data related to 
pharmacists’ and interns’ participation; and 
4. requires DPH to notify DCP in writing if it waives the assistance 
program’s annual audit requirement and, regardless of this 
waiver, allows DCP to require an audit of the program, to be 
submitted to the department and the General Law Committee, to 
examine whether it is appropriately serving pharmacists and 
interns. 
BACKGROUND 
Health Professional Assistance Program  
By law, before a health professional can enter the program, a medical 
review committee must (1) determine if he or she is an appropriate 
candidate for rehabilitation and participation and (2) set terms and 
conditions for participation. The program must include mandatory 
periodic evaluations of each participant’s ability to practice with skill 
and safety and without posing a threat to the health and safety of any 
person or patient (CGS § 19a-12a). 
COMMITTEE ACTION 
General Law Committee 
Joint Favorable Substitute 
Yea 23 Nay 0 (03/02/2023)